Viewing Study NCT05032651


Ignite Creation Date: 2025-12-24 @ 11:54 PM
Ignite Modification Date: 2026-01-17 @ 6:28 AM
Study NCT ID: NCT05032651
Status: UNKNOWN
Last Update Posted: 2021-10-13
First Post: 2021-08-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Use of a Novel Artificial Intelligence Assisted Platform to Assess Optimal Dosing and Treatment Strategy of Erythropoiesis-stimulating Agents (ESA) in Hemodialysis Patients
Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None End Stage Renal Disease on Dialysis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None End Stage Renal Disease View
None Erythropoiesis stimulating agent View
None Artificial intelligence assisted platform View